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Human monoclonal rheumatoid factors (RFs)' can be divided by polyclonal
antisera into three idiotypic families Wa, Po, and Bla (1-3). The predominant
group is the Wa family, representing ^"60% ofthe RFs isolated from the plasma
of patients with mixed cryoglobulinemia (2). Also, patients with rheumatoid
arthritis and other autoimmune diseases often have polyclonal antibodies that
bear theseidiotypes(4, 5). A numberofinvestigators have analyzed themolecular
nature ofthe Wa idiotype with major emphasis on the light chain variable region
(6-9). The highly homologous amino acid sequences of several of these light
chains as well as studies with antipeptide sera have suggested that there may be
only a single VK gene segment used in the construction ofthese molecules. The
VK gene 321 has been cloned and sequenced (10), and is thought to represent
the germline VK gene segment that gives rise to the light chains of this family
of autoantibodies. Whereas among Wa family members approximately fifteen
light chain variable regions have beencompletely or nearly completely sequenced
(8, 11, 12), before this study only two other Wa heavy chain variable regions
had been sequenced (13).
Several studies have documented that RFs express several shared public
idiotopes (14-16). However, because there was little or no sequence information
available on the molecules used in such studies, an interpretation of the critical
amino acids involved in the idiotypic determinants was not possible.
This paper presents the amino acid sequences of both the heavy and light
chain variable regions of two additional members of the Wa family, BOR and
KAS. In addition to the sequence information, the antigen binding specificities
and expressed idiotopes of these and some previously sequenced Wa members
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has been determined. The data suggest that Wa family heavy chain variable
regions appear to be restricted to the VHI subgroup and have a uniform-sized D
region such that the third complementarity-determining region (CDR) of the
heavy chain is about the same size . In addition, all Wa RI's sequenced to date
use a JH4 gene segment. This striking restriction in VH , DH, and JH structures
suggests that these elements, along with the previously described light chain
structures, may play a major role in determining the antigenic specificity and
idiotypy of these molecules.
Materials and Methods
Preparation of RFs.
￿
Monoclonal IgM RFs were isolated from the washed cryoprecipi-
tates (with cold PBS) from the plasma of patients BOR and KAS who had mixed
cryoglobulinemia (the plasma was kindly donated by R. Wistar). Monoclonal IgM was
separated from polyclonal IgG by gel filtration using an S300 column (170 X 2.5 cm,
Pharmacia Fine Chemicals, Piscataway, NJ) in PBS, at room temperature. The IgM was
>95% pure as analyzed by SDS-PAGE.
Preparation ofFabs ofIgM RFs.
￿
Monoclonal IgM RFs were digested in the presence of
cysteine (Sigma Chemical Co., St. Louis, MO) with mercuric papain (Worthington Bio-
chemicals, Malvern, PA) at 1 :100 for 16 h at room temperature, as previously described
(17). The Fabs were first purified by gel filtration and then by ion-exchange chromatog-
raphy (17).
Preparation ofFragmentsfor Protein Sequencing.
￿
The purified Fab fragments were first
chemically cleaved with an equal weight of CNBr in 70% formic acid for 24 h at room
temperature. The mixture was diluted with water and then lyophilized. After CNBr
cleavage, the peptides were resuspended in 0.2% trifluoroacetic acid (TFA), and small
cleavage products were separated from large ones by reverse-phase chromatography using
a C4 column (Vydac, Hesperia, CA) and a linear gradient of 0.1 % TFA in water to 0.1
TFA in 50% acetonitrile, 15% isopropanol for 90 min at a flow rate of 1 ml/min. The
large fragments (which eluted at the end of the gradient) were pooled and subjected to
complete reduction and alkylation in guanidine (CRA) as previously described (12). These
peptides were separated by reverse-phase chromatography using the conditions described
above, however, initially the C4 column was used to remove the salts used in the complete
reduction and alkylation procedure. To optimally separate the peptides, we used reverse-
phase chromatography with a C18 column (Aquapore RP300; Brownlee, Santa Clara,
CA) with a linear gradient of 0.1 % TFA in water to 0.1 % TFA in 50% acetonitrile for
90 min at a flow rate of 1 ml/min . Peptides that were 335 amino acids in length were
further digested with trypsin either with or without citraconylation as the case required
(12). These peptides were separated by reverse-phase chromatography using the C18
column as above.
Removal of NH2-terminal Pyroglutamic Acid from Heavy Chain.
￿
Initial studies proved
that the NH2 terminus of the heavy chain was resistent to Edman degradation . Thus, the
heavy chain NH2-terminal peptide (after chemical cleavage with CNBr) was identified by
compositional analysis using a Beckman 6300 amino acid analyzer (Beckman Instruments,
Palo Alto, CA). Using pyroglutamic amino peptidase according to the method of Podill
et al. (18), the cyclized NH2-terminal amino acid was successfully cleaved. This CNBr
peptide, after the aminopeptidase treatment, was separated from the intact enzyme by
reverse-phase chromatography using the C18 column as above.
Protein Sequencing.
￿
Peptides were subjected to an automated protein sequencer using
either the gas-phase model 470 Applied Biosystems sequencer (Foster City, CA) with the
model 120 on-line HPLC phenylthiohydantoin (PTH) amino acid identification system,
cr a Beckman spinning cup model 890M sequencer. In the latter case, the PTH amino
acids were identified using a NovaPac column in a Waters model 840 HPLC system
(Millford, MA). To help identify the peptides before sequencing, compositional analyses
of the peptides were done by amino acid analysis.552
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Idiotype and Idiotope Analysis.
￿
The purified RFs were analyzed for expression of the
Wa idiotype using three different polyclonal typing antisera raised to Wa RFs by hemag-
glutination (kindly performed by D. Posnett, Cornell University Medical Center, New
York [16], and V. Agnello, Lahey Clinic, Burlington, MA [19]), and by ELISA. In the
latter case, polystyrene plates were coated with BOR or KAS (10 ug/ml) in PBS by
incubation at 37°C for 2 h, and dilutions of F(ab')2 of polyclonal antisera in PBS/0.05%
Tween 20 were added to the wells. Bound antisera were detected using peroxidase-
conjugated sheep anti-rabbit Ig antisera. Analyses of expressed idiotopes on these mole-
cules were performed using an ELISA with a panel of monoclonal antibodies that had
been raised to a number of human mRFs. For the monoclonal antibodies G6, HI (14),
C7, B12 (14) G8, C8 (R. A . Mageed, manuscript in preparation) and 17-109 (20) (kindly
donated by D. Carson, Scripps Clinic and Research Foundation, La Jolla, CA), the ELISA
plates, coated as above, were incubated with monoclonal antibodies diluted (1 :10-') in
PBS/Tween. The bound mAbs were detected with peroxidase-conjugated sheep anti-
mouse Ig antisera. For the monoclonal antibodies 86.3, 108.12, 102.2, and 128.4 (kindly
donated by D. Posnett [16]) the ELISA plates were coated with BOR or KAS (10 wg/ml)
in carbonate/bicarbonate buffer, pH 9.6, for 16 h at 4° C. The monoclonal antibodies
that had been purified by protein A affinity chromatography (Pierce Chemical Co.,
Rockford, IL) were added at a concentration of 1 wg/ml in PBS and incubated for 2 h at
37°C. Bound antibodies were detected using peroxidase-conjugated goat anti-mouse Ig
antisera.
Reactivity with Antisera Raised to SIE CDR Peptides.
￿
The heavy and light chains from
BOR and KAS RFs were separated on SDS-PAGE and immunoblotted with antisera to
the peptides PSL2, PSL3, and PSH3 derived from the RF SIE and PPH2, and PPH3
derived from the RF POM as previously described (12, 21-23).
Antigenic Specificity of the mRFs.
￿
The antigenic specificities of the mRFs for different
subclasses of IgG were determined independently by ELISAand hemagglutination. ELISA
plates were coated with myeloma proteins of the appropriate subclass of IgG (10 ug/ml)
in carbonate/bicarbonate buffer, pH 9.6, for 16 h at VC. C. The RFs, either at 1 or 0.5
;ig/ml (diluted in PBS) were incubated at room temperature for 4 h. Bound RFs were
detected with peroxidase-conjugated goat anti-human IgM (Fc-specific) antisera. For the
hemagglutination assay, sheep red blood cells were passively sensitized with the Ig (isotype
or subclass) in question using chromic chloride. The starting concentration of RF was 110
tag/ml (BOR), 83 Ag/ml (KAS), or 100 Ag/ml (SIE).
Results
Expressed Idiotype and Idiotope.
￿
The results of assays determining the nature
of the idiotype and idiotopes expressed by BOR, KAS, SIE, and WOL are
presented in Table I . As can be seen, both BOR and KAS are representatives of
the Wa idiotypic family of human RFs . SIE and WOL had previously been
determined to be members of this idiotypic family (11) . From the results of
ELISA with monoclonal antibodies that are thought to recognize determinants
specific for human RFs it can be seen that BOR, KAS, and SIE show similar
reactivities. The slight differences in the degree of the reactivity of these RFs
with the antiidiotopes may either be due to the degree of purity of the RFs (the
BOR and SIE preparations were >98% pure while the KAS preparation was
^-95% pure), or the degree of denaturation of the IgM (the SIE RF preparation
was >7 yr old). Based on the reactivity of these monoclonal antibodies with a
number of other RFs (as yet unsequenced), BOR, KAS, and SIE appear to belong
to a Wa subfamily. However, an epitope was detected on BOR and SIE by mAb
G8 that was not detected on the KAS molecule, suggesting that the Wa family
can be further subdivided.
Antigenic Specificity.
￿
The subclasses of human IgG to which BOR, KAS, andNEWKIRK ET AL.
TABLE I
Expression ofIdiotype/Idiotopes by Completely SequencedHuman RFs
Results areexpressed as: -, negative; +, OD4920.05-0.5; ++, 0.51-1.0; +++,
1.01-1.5 ; ++++, 1.51-2.0.
* RIA results(16).
t Hemagglutination assay (12, 19).
§ELISA.
TABLE II
Specificity ofBOR, KAS, and SIE RFsfor IgG Subclasses
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For ELISA, results are expressed as: -, negative; +, OD492 0.05-0.5; ++, 0.51-1.0;+++, 1.01-1.5;
++++, 1.51-2.0. Hemagglutination (HA) titer log 2.
SIE bind are presented in Table II . All three RFs show similar binding to IgGI
as well as to Fc (IgGI). However, BOR binds only weakly if at all to the other
human IgG subclasses, while KAS binds well to IgG3. SIE recognizes the IgG
subclasses 1-3, and weakly 4, but binds best to IgGl . None of these RFs bound
to either IgM, IgA, or light chain dimers of either K or X isotype. Slight
discrepancies in the bindingprofiles were obtained by the two methods, possibly
Antisera/
antibody Specificity
Idiotype/idiotope on RF
BOR KAS SIE WOL*
Anti-GLO$ Wa ++++ ++++ ND ND
Anti-McD$ Wa ++++ ++++ ND ND
Anti-KO§ Wa ++++ ++++ ++++ ND
17-109§ Wa LC +++ ++ ++ ND
H1 Wa HC (two RFs) - - - ND
B12 Kill ++++ +++ +++ ND
C7 Kill ++++ +++ +++ ND
G8 Conformational epitope +++ - +++ ND
G6 WaHC +++ ++ ++ ND
C8 IgML-RF - - - ND
86.3 RF-CRI + + + -
108.12 KIIIb ++ + + ++++
102.2 KIM +++ ++ + ++
128.4 IgMK + + - -
Isotype/subclass
of Ig BOR
ELISA HA titer
Human
KAS
ELISA
RF
HA titer
SIE
ELISA HA titer
IgG pool ND 6 ND 8 ND 11
Fc(IgGl) +++ 11 +++ 10 +++ 22
IgGI +++ 5 +++ 5 +++ 9
IgG2 + 0 +++ 2 ++ 0
IgG3 - 1 ++++ 4 ++ 0
IgG4 - 1 ++ 3 + 0
BJ ND 0 ND 0 ND 0
IgM ND 0 ND 0 ND 0
IgA ND 0 ND 0 - 0554
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FIGURE 1 .
￿
The complete amino acid sequences of the light chain variable regions of four
monoclonal RFs of the Wa idiotypic family, along with the genomic KIIIb sequence (321).
Amino acids are given in the single-letter code, numbered according to Kabat (24). Identical
amino acids are represented by dashes, changes in amino acids are indicated. Boxed areas
delineate the CDRs (CDR I-III). SIE and WOL sequences (11), 321 sequence (10). Reactivity
to the antipeptide sera from immunoblots PSL2 refers to the peptide derived from SIE
positions 49-61, PSL3 refers to the peptide from SIE positions 88-99. The results from
immunoblots with the antipeptide sera for WOL as previously reported (9, 25).
due to the different myeloma proteins (IgG) that were used in different labora-
tories .
Amino Acid Sequences of Light Chain Variable Regions of BOR and KAS.
￿
The
sequences derived from tryptic peptides ofthe variable regions ofthe light chains
ofBOR and KAS are presented in Fig. 1. NH2-terminal sequence analysis on the
first 38 amino acids of the intact BOR light chain and 35 amino acids for the
KAS light chain aided in the alignment of the peptides. The remaining peptides
were positioned according to the sequences ofrelated light chain variable regions
ofthe KIIIb subgroup. For comparison, the germline VK 321 sequence of Chen
et al. (10) and two other Wa family RFs previously sequenced in our laboratory
are presented (11).
Amino Acid Sequence of the Heavy Chain Variable Regions ofBOR and KAS.
￿
The
sequences derived from peptides of the variable regions of the heavy chains of
BOR and KAS are presented in Fig. 2. For comparison, the other Wa RFs, SIE
and WOL, (13), EU (not an RF) (27), and one representative of the translated
DNA sequence ofa rearranged gene (J. V. Ravetch and S. Korsmeyer, personal
communication), all members ofthe human VHI subgroup, are presented. While
there are only five complete protein sequences in this subgroup, they can be
easily subdivided into subsubgroups with BOR, KAS, and EU members of one
subsubgroup designated VHIa, all having >85% amino acid identity (Table 111,
positions 1-94), and SIE and WOL representatives of other subsubgroups of
VHI termed VHIb, c, etc. Other sequences derived from DNA (both germline
and rearranged) ofmembers of this family (28-29) showa diminishing gradation
of relatedness to the VHIa subsubgroup (Table 111).BOR
KAS
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FIGURE 2.
￿
The complete amino acid sequences of the heavy chain variable regions of four
Wa family RFs BOR, KAS, SIE, and WOL, with sequences of other VHI members, EU
(protein, not an RF) and 783 (from a rearranged DNA sequence, specificity unknown) for
comparison. Identical amino acids are represented by dashes, changes in amino acids are
indicated. Boxed regions delineate the CDRs. EU (27), SIE, WOL (13), 783 (Ravetch and
Korsmeyer, personal communication). The reactivity to anti-PSH3 sera from immunoblots.
PSH3 refers to the SIE positions 95-102. WOL reactivity was previously reported (25).
TABLE III
Amino Acid Identity in VIMembers (Residues 1-94)
BOR KAS 783 EU
55 5
Residues are numbered according to Kabat (24); 783 (Ravetch and Korsmeyer, personal communi-
cation), EU (27), HG3 (28), 266BL (29), SIE, WOL (13). Numbersare percent homology. The VHIa
subsubgroup has been boxed.
Reactivity with Antipeptide Sera.
￿
The results of studies determining the reac-
tivity with BOR and KAS ofthe antipeptide sera raised to peptides derived from
the heavy and light chain CDRs ofSIE are presented in Figs. 1 and 2. Both BOR
and KAS show reactivity with the light chain-specific peptide antisera (Fig. 1)
that bind to the second or third CDRs ofSIE (PSL2 and PSL3). The anti-PSL2
sera bound to the BOR light chain to a greater extent than to the KAS light
chain, while the opposite pattern of reactivity was observed with the anti-PSL3
sera that bound best to the KAS light chain. The BOR but not the KAS heavy
chain was recognized by the antipeptide sera that is directed to the CDR3 ofthe
PSH3 CDR I
20 40
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SIE heavy chain (PSH3) (Fig. 2). This is the first time that any RF heavy chain
other than SIE has been found to significantly react with this antisera (23, 25).
There was no detectable binding of the antipeptide sera raised to the POM
peptides (PPH2 and PPH3) to any ofthese RFs (results not shown).
Discussion
This study provides evidence that human RFs of the Wa idiotypic family have
a conserved primary structure, suggesting that they may be derived from rela-
tively few germline VH, DH, JH, VK, and JK gene elements. Several lines of
evidence had suggested previously that the variable region of the light chain of
all the Wa family members appears to be derived from a single VKIIIb gene
segment(10). As can be seen from Fig. 1, BORand KAS VLaminoacidsequences
are 93% identical, and the other RFs are >92% identical (positions 1-96).
Although the mutation rate has notclearly been established for human V regions,
it is probably similar to mouse V regions, which is estimated to be 10-s mutations
per cell base cell division (approximately one mutation in the coding region per
three generations) (30). Considering that these RFs are from outbred, unrelated
humans, and that the number ofB cell generations is not known at the time the
sera were harvested, it is interesting to note that the light chain sequences of
SIE, BOR, KAS, and WOL (1-96) can be explained by a minimum of two to
four nucleotide changes (silent changes are unknown) from the proposed ances-
tral K111b 321 gene.
Previously onlyJK1 andJK2 gene segments were seen in conjunction with the
VKIIIb region at a ratio of 3:2 in the Wa family. In studies of mouse RFs, a
similar finding of high frequency usage ofthe proximal JK segments (J1 and 2)
has been found (31). The KAS RF is the first described ofthis Wa family to use
aJK4 gene segment. BOR uses the more commonly used JK1 gene segment.
Thejunctional amino acid (at position 96) between VK andJK has been shown
in a number of systems to be highly variable and important for antigen binding.
In the 13 completely sequenced light chains or Wa RFs (8, 11, 12) six different
amino acids have been seen at this position, with Arg present most frequently
(31%). The Gin at the VJ junction in BOR was previously seen in the RF SIE.
While a number ofgenetic mechanisms can give rise to this amino acid, with the
knowledge of the nucleotide sequence of the VKIIIb 321 germline gene that
presumably gives rise to the light chains of these RFs (10), and the genomic
sequence of the human JK1 gene segment (26), it is likely that the junctional
amino acid Gln in BOR and SIE is encoded by CAG, with the 3' end of the V
gene segmentcontributing the C, an A added by one ofthe diversity mechanisms,
and the last nucleotide of the codon coming from the G from the 5' end of the
germline JK1 Trp codon. In KAS, the junctional Phe codon is most likely to be
encoded by TTC and can be explained by adding a T (possibly by a terminal
transferase) after the Pro codon (CCT) in the germline V region, and then by
intracodonic mechanisms thatjoin the TC from the Leu codon (CTC) from the
5' end of the JK4 germline gene element. This is the first time that a Phe has
been seen at this highly variablejunctional position.
Studies with antipeptide sera raised to SIE light chain CDRs reveal that the
BOR light chain is recognized by theantipeptide sera to PSL3 even though thereNEWKIRK ET AL.
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is a substitution of Asn for Ser at position 93 in the light chain, whereas WOL,
which has the Ser but multiple differences after the Ser, is not (25). From the
combined results ofsequence information and the reactivity ofthis antisera to a
number ofWa RFs (8, 12) is was previously deduced that the region ofthe light
chain recognized by the anti-PSL3 sera was amino acids 88-93. It had been
found that a substitution of an Ala at position 93 reduced the reactivity of the
antisera to PSL3 by 50% (8), and it appears that the Asn substitution also results
in a similarly reduced binding. It is difficult to explain the lack of reactivity of
the anti-PSL3 sera to WOL given these data. The KAS light chain is the first
Wa light chain sequenced to have a substitution at position 59 (framework 3)
within the region to which the antisera to the peptide PSL2 was raised. There
appears to be a diminished reactivity of the anti-PSL2 sera to the KAS light
chain, probably due to the Val for Ile substitution.
The similarities of the heavy chain V regions of the four Wa members
sequenced to date show that BOR and KAS are more related to one another
than are SIE and WOL (Fig. 2). In the mouse, families of heavy chain VH gene
segments have been defined as sequences that have >80% identity at the DNA
level. In man, the subdivision of heavy chain V region proteins has been based
on >75% identity in the framework regions. BOR, KAS, SIE, and WOL show
->75% identity, and thus by definition are members of the VHI subgroup.
However, when the heavy chain V regions (positions 1-94) are compared, it can
be seen that the second CDR varies considerably between BOR/KAS and
SIE/WOL. The lack ofamino acid identity in this region cannot be explained
by translation in another reading frame when the DNA sequence of the related
VHI 783 rearranged gene is used. We propose a new designation, VHIa, to
include proteins that have >85% amino acid identity to EU in the V region
(positions 1-94), and >75% amino acid identity in CDRII. BOR and KAS by
thisdefinition would be members ofthis sub-subgroup, excluding SIE and WOL.
In the VHIII subgroup ofhuman immunoglobulin heavy chains, where there is
considerably more amino acid sequence data available, the second CDR also
appears to be a region that is highly variable (24) and has been seen to have a
shifted reading frame in this region (32), and, in the extreme, to have been
deleted (33). Perhaps, in man, a number of diversity mechanisms are active in
this region. However, it is notable that in the Po idiotyppc family of RFs, the
CDRII ofthe VH as well as the entire VH are relatively invariant for the proteins
sequenced to date (34), and may be important in the expression of the Po
idiotype.
As only a limited number of complete sequences of VHI subgroup members
exist (five protein, three DNA) it would appear that the VHI subgroup is used
less frequently than the other known VH subgroups. Interestingly, halfof these
known sequences are from Wa family RFs. However, since all of the proteins (in
the VHI subgroup) sequenced to date have cyclized NH2 termini, thus rendering
the protein resistant to Edman degradation, the limited number of protein
sequences available could be due to an investigator bias. Serological studies have
indicated that human VHI regions are present in 16% ofexpressed immunoglob-
ulins (VHII, 34%; VHIII 50%) (35). The VHIII subgroup has been found by
sequence analysis to be present on 20-75% ofpolyclonal normal Ig, depending558
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The amino acid sequences of the heavy chain D andJ regions of four Wa family
human RFswith the genomic sequence of theJH4 (45) forcomparison.
on the isotype (36). From studies using VH DNA probes in cosmid clones, the
ratio ofVHI/II/III appears to be 23:8:30 (37).
The organization of V region genes in the mouse appears to be in discrete
families (38, 39), although some exceptions do exist (40). In human VK and
rabbit VH, however, it appears that V region genes are not organized into
discrete families but are interdigitated (41, 42). Some human is pseudogenes,
three of which have been sequenced (those contain major abnormalities that
would prevent processing) are found on chromosomes 1, 15, and 22 (43), while
the transcribable K genes are encoded on chromosome 2. Similarly, in the human
VH gene organization there is considerable interdigitation ofthe three subgroups
(37).
From our study it appears that the BOR and KAS VH may be derived from
one VHIa gene (each would have a minimum of 10 mutations from a consensus
VHIa sequence) while SIE and WOL are likely to be single representatives of
other VHI genes. Thus, a minimum of three genes (all restricted to the VHI
subgroup) could encode RFs ofthe Wa idiotypicgroup. Theothermajor idiotypic
family, Po (2, 34) seems to be equally restricted, but to the VHIII subgroup. We
have recently sequenced two additional members of this latter family (an IgM
and an IgG RF) that also have a VHIII heavy chain, which will be the subject of
another communication (44).
It appears that, although at least three related genes can encode the heavy
chain V gene segments of Wa RFs, the critical features that determine both the
antigenic specificity for the Fc portion of IgG (one or more subclasses) and the
idiotypic expression are the nature of the heavy chain D and J gene segments
(Fig. 3). All four of these Wa family members have a D region that is 9 or 10
amino acids long (9 is the average size of expressed human D gene segments).
However, this very restricted limit in size (the variation seen in other human
immunoglobulins of all families is 5-16) is probably meaningful in the context
of the nature of the binding pocket. A similar conservation in the size of the
CDRIII in the heavy chain ofmouse RFs has also been observed (31). The other
members of this human VH subgroup have a greater variation in the number of
amino acids in this region of the antibody molecule. The D regions of these RFs
do not match any published sequence ofhuman D regions (45, 46), however the
KAS and EU D segments appear to be highly related. Interestingly, all of the
Wa RFs have D segments that begin with a Glu (Fig. 3), and if the genomic
sequence of these genes is similar to HG3 (Table III), this can be explained by
adding either A or G to the existing GA (3' of the Arg codon in the germline)
thus creating the triplet codon for Glu. This Aor Gcould be supplied by the D
gene segment or by another N segment addition mechanism. Three ofthe four
RFs have D segments that end (at thejunction of DJ) with Pro. An explanationNEWKIRK ET AL.
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ofthis requires knowledge ofthe D gene segments at the DNA level as it is likely
that theJ gene segment contributes only the third nucleotide (which can be any
base in the case ofPro). These Glu and Pro residues may be importantin antigen
specificity and/or the expression ofidiotypy, as they occur more frequently than
random chance would predict.
Perhaps the most striking structural feature ofthe Wa family RFs is that they
all use the JH4 gene segment (Fig. 3), confirming the previous observations of
Andrews and Capra (47) and adding furthersupport for theirargument that this
region may be crucial for the Wa crossreactive idiotype. Even though all four
members of this family use the JH4 gene segment, there are slight variations
among the individuals. It can be seen that WOL likely uses a longer portion of
this JH gene element (the Phe to Tyr and the Asp to Tyr substitutions in WOL
are both one-nucleotide changes) whereas BOR, KAS, and SIE all use the same
size of JH. Also, KAS has a Phe instead of Tyr in the JH4 (a one-nucleotide
change), that, coupled with the charged group (Arg) in the D section probably
create a stretch ofamino acids that is not recognized by the antipeptide sera that
binds to the SIE and BOR CDRIIs. Thus the common structural features of
the Wa family of RFs are a heavy chain variable region consisting of a VHI
subgroup gene segment, a 9- and 10-amino-acid D region beginning with Glu
and ending with Pro (in three ofthe four), and aJH4 gene segment.
Although BOR and KAS as well as SIE and WOL are all members of the Wa
idiotypic family, BOR and KAS are much more related to one another in the VH
region than to SIE or WOL. The data from studies using the panelofmonoclonal
antiidiotopes also support a close relationship shared by all three RFs (BOR,
KAS, and SIE). Studies with the WOL molecule are incomplete due to the
present unavailability ofthe molecule. Itis likely that the conformational idiotope
recognized by the mAb G8 is in the region of amino acids 94-100 of the light
chain, with thejunctional Gin pivotal, coupled with the stretch ofamino acids in
the heavy chain CDRIII that BOR and SIE share. Studies using anti-PSH3 sera
confirm the latter, as SIE and BOR show common reactivity to this antisera,
which detects CDRIII of the SIE heavy chain. When the amino acid sequences
of SIE and BOR are compared in this region, there is a stretch of only five
identical amino acids (Asn-Pro-Phe-Asp-Tyr) at the COOH terminus of this
peptide that probably is responsible for the crossreactivity of the antipeptide
sera. KAS neither shares the idiotope recognized by the mAb G8 nor is reactive
with the anti-PSH3 sera, and has major amino acid differences from SIE and
WOL in the CDRIIs ofboth heavy and light chains.
There probably exists within the Wa idiotypic family a number ofsubfamilies
defined by the fine specificity of antigen binding and expression of idiotopes.
Until further sequence information on other Wa members becomes available
one can not as yet determine their number and size. Also the exact binding site
on the Fc portion of the IgG molecule has long been in doubt. It is likely that
different members of this family bind different parts of Fcy. It has been
speculated that the binding site for polyclonal RFs is in the cleft between C-y2
and Cy3, as it is inhibitable by protein A (48). However, since KAS but not BOR
binds IgG3, a subclass that does not bind protein A (49), a different portion of
the Fc molecule may be recognized by this RF although this does not preclude560
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the binding site being in the Cy2/Cy3 region. The major differences in the KAS
and BOR/SIE amino acid sequences are in the CDRIIIs of the heavy and light
chains . These areas are likely candidates that could confer a difference in the
antigen-binding specificity ofthe KAS molecule. An IgM monoclonal RF (not of
the Wa idiotypic family) has been shown (50) to bind to a discontinuous epitope
on the Fc of IgG, but is dependent on the presence of the His at position 435
(near the COOH terminal ofthe Cy3 domain).
A number of investigators have postulated that the light chain (possibly
framework regions) is the common element in determining an RF, and while this
may be true in the mouse (32) it is unlikely to be so in humans. Another human
Ig (EV1-15) sequenced recently in our laboratory, which uses a KIIIb light chain,
neither has RF activity nor expresses the Wa idiotype. The Wa idiotypic RFs
appear to have in common the KIIIb light chain, a heavy chain VHI, a D region
that is uniform in size beginning with a Glu and ending with a Pro, and a JH4.
Evidence from three-dimensional studies on these molecules should help deter-
mine the nature of the antigenic binding site and what residues are critical for
the expression of idiotypy. BOR and KAS have recently been crystallized and
await further resolution ofthese issues (17).
It is interesting to compare the human Wa idiotypic family of human RFs to
another well-characterized idiotypic family, that of the antiarsonate response in
the A/J mouse. Extensive studies (51-53) have shown that these molecules use
very specific heavy chain V-DJs and light chain V-J to both bind antigen and
express the major crossreactive idiotype (51-53). In fact, certain amino acids
such as the Ser at position 99 in the heavy chain have been well characterized as
to their essential role (in this case in antigen binding).
Thus, there is a growing consensus that RFs of both the Po and Wa idiotypic
familiesare derived from only a limited number ofgermline gene segments. The
presence of these idiotypes in both mixed cryoglobulinemia and in rheumatoid
arthritis suggests either that there are common gene segments present in the
majority of the population that are activated in these diseases by an as yet
unknown mechanism, or that only certain individuals, those carrying these gene
segments, are indeed susceptible to these diseases. The availability of genetic
probes for these gene segments should facilitate an answer to these questions.
Summary
Evidence derived from the complete amino acid sequences of the variable
regions ofboth the heavy and light chains of two members (BOR and KAS) of
the Wa idiotypic family ofhuman rheumatoid factors suggests that not only are
the light chains of these molecules derived from possibly one variable region
gene segment, but the heavy chain variable regions are all derived from the VHI
subgroup of human V region genes. These molecules exhibit a surprising
conservation in the size of D region, and all use the JH4 gene element. This
restriction in use of VL, VH, D, andJH suggests all of these elements may play a
crucial role in either antigen binding and/or expression of the crossreactive
idiotype.
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